Početna › Kronična faza mijeloične leukemije › Washington
Kliničke studije za Kronična faza mijeloične leukemije u državi Washington
3 studija za Kronična faza mijeloične leukemije traži sudionike na lokacijama u državi Washington.
Gradovi u državi Washington
Službeni tekst studije (engleski)
Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1136, Edmonds
- Ascentage Investigative Site #1135, Issaquah
- Ascentage Investigative Site #1806, Seattle
- i još 1
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 15. ruj 2026. · NCT06423911A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
- Fred Hutchinson Cancer Research Center, Seattle
- MultiCare Health System Institute, Tacoma
- Northwest Medical Specialties, Tacoma
U tijeku regrutacijaOpažajna studija
Od 18 do 100 godina · Oba spola · Ažurirano 20. srp 2026. · NCT07091019A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
- Fred Hutchinson Cancer Center, Seattle
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 12. sij 2026. · NCT06163430Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.